XPC and colorectal carcinoma: They found that the XPC rs2228001 A > C polymorphism was significantly associated with increased CRC risk under the heterozygous (OR = 1.40, 95% CI = 1.16–1.69) and dominant (OR = 1.31, 95% CI = 1.10–1.56, p = 0.001) genetic models.